Hortobagyi GN - Search Results

1

Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.

Yao S, Barlow WE, Albain KS, Choi JY, Zhao H, Livingston RB, Davis W, Rae JM, Yeh IT, Hutchins LF, Ravdin PM, Martino S, Lyss AP, Osborne CK, Abeloff MD, Hortobagyi GN, Hayes DF, Ambrosone CB. Yao S, et al. Among authors: hortobagyi gn. Breast Cancer Res Treat. 2010 Nov;124(2):433-9. doi: 10.1007/s10549-010-0840-0. Epub 2010 Mar 23. Breast Cancer Res Treat. 2010. PMID: 20309628 Free PMC article. Clinical Trial.

2

Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.

Hortobagyi GN, Blumenschein GR, Tashima CK, Buzdar AU, Burgess MA, Livingston RB, Valdivieso M, Gutterman JU, Hersh EM, Bodey GP. Hortobagyi GN, et al. Cancer. 1979 Aug;44(2):398-405. doi: 10.1002/1097-0142(197908)44:2<398::aid-cncr2820440205>3.0.co;2-t. Cancer. 1979. PMID: 383255

3

Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapy.

Buzdar AU, Tashima CK, Blumenschein GR, Hortobagyi GN, Yap HY, Krutchik AN, Bodey GP, Livingston RB. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer. 1978 Feb;41(2):392-5. doi: 10.1002/1097-0142(197802)41:2<392::aid-cncr2820410202>3.0.co;2-7. Cancer. 1978. PMID: 630529

4

Overview of new treatments for breast cancer.

Hortobagyi GN. Hortobagyi GN. Breast Cancer Res Treat. 1992;21(1):3-13. doi: 10.1007/BF01811959. Breast Cancer Res Treat. 1992. PMID: 1356516

5

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.

Buzdar AU, Kau SW, Hortobagyi GN, Ames FC, Holmes FA, Fraschini G, Hug V, Theriault RL, McNeese MD, Singletary SE. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer. 1992 Jan 15;69(2):448-52. doi: 10.1002/1097-0142(19920115)69:2<448::aid-cncr2820690229>3.0.co;2-k. Cancer. 1992. PMID: 1728373

6

Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.

Macheledt JE, Buzdar AU, Hortobagyi GN, Frye DK, Gutterman JU, Holmes FA. Macheledt JE, et al. Among authors: hortobagyi gn. Breast Cancer Res Treat. 1991 Aug;18(3):165-70. doi: 10.1007/BF01990032. Breast Cancer Res Treat. 1991. PMID: 1756259 Clinical Trial.

7

Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?

Buzdar AU, McNeese MD, Hortobagyi GN, Smith TL, Kau S, Fraschini G, Hug V, Ellerbroek N, Holmes FA, Ames F, et al. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer. 1990 Feb 1;65(3):394-9. doi: 10.1002/1097-0142(19900201)65:3<394::aid-cncr2820650303>3.0.co;2-2. Cancer. 1990. PMID: 2297630

8

Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients.

Sutton R, Buzdar AU, Hortobagyi GN. Sutton R, et al. Among authors: hortobagyi gn. Cancer. 1990 Feb 15;65(4):847-50. doi: 10.1002/1097-0142(19900215)65:4<847::aid-cncr2820650402>3.0.co;2-a. Cancer. 1990. PMID: 2297653

9

Trilostane with hydrocortisone in treatment of metastatic breast cancer.

Chu PS, Buzdar AU, Hortobagyi GN. Chu PS, et al. Among authors: hortobagyi gn. Breast Cancer Res Treat. 1989 Mar;13(2):117-21. doi: 10.1007/BF01806523. Breast Cancer Res Treat. 1989. PMID: 2659103 Clinical Trial.

10

Role of adjuvant chemotherapy in male breast cancer.

Patel HZ 2nd, Buzdar AU, Hortobagyi GN. Patel HZ 2nd, et al. Among authors: hortobagyi gn. Cancer. 1989 Oct 15;64(8):1583-5. doi: 10.1002/1097-0142(19891015)64:8<1583::aid-cncr2820640804>3.0.co;2-q. Cancer. 1989. PMID: 2676137 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,107 results

Search Page

Filters